Invention Grant
- Patent Title: FGF21 mimetic antibodies and uses thereof
-
Application No.: US17127600Application Date: 2020-12-18
-
Publication No.: US11692046B2Publication Date: 2023-07-04
- Inventor: Regis Cebe , Stephane Olland , David Langdon Yowe
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: Clark & Elbing LLP
- The original application number of the division: US15890302 2018.02.06
- Main IPC: C07K16/40
- IPC: C07K16/40 ; C07K16/28 ; A61K39/395 ; A61K39/00
Abstract:
The present disclosure relates to monoclonal antibodies and antigen-binding fragments thereof that bind to human β-klotho, and pharmaceutical compositions and methods of treatment comprising the same.
Public/Granted literature
- US20210171659A1 FGF21 Mimetic Antibodies and Uses Thereof Public/Granted day:2021-06-10
Information query
